Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized double-blind study of amlodipine + irbesartan in essential hypertension with inadequate response to irbesartan
jRCT2080220753Phase 2
- Sponsor
- Sumitomo Pharma
- Start
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of amlodipine and irbesartan in essential hypertension, sponsored by Sumitomo Pharma.
02
Drugs
amlodipineirbesartan
03
Conditions
essential hypertension
Beyond the preview
Go deeper on jRCT2080220753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220753.